{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T14:24:40Z","timestamp":1774621480980,"version":"3.50.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,22]],"date-time":"2026-02-22T00:00:00Z","timestamp":1771718400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T00:00:00Z","timestamp":1774569600000},"content-version":"vor","delay-in-days":33,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cytogenet"],"DOI":"10.1186\/s13039-026-00753-8","type":"journal-article","created":{"date-parts":[[2026,2,22]],"date-time":"2026-02-22T18:34:35Z","timestamp":1771785275000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Optical genome mapping reveals a recurrent translocation, t(14;16), in T\/myeloid mixed phenotype acute leukemia: report of two cases"],"prefix":"10.1186","volume":"19","author":[{"given":"Joanna","family":"Lum","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica","family":"Anderson-Calleja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimberly","family":"Van Dine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily","family":"Manion","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anamarija M.","family":"Perry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Boyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6650-1698","authenticated-orcid":false,"given":"Lina","family":"Shao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,22]]},"reference":[{"issue":"11","key":"753_CR1","doi-asserted-by":"publisher","first-page":"3163","DOI":"10.1182\/blood-2010-10-314682","volume":"117","author":"E Matutes","year":"2011","unstructured":"Matutes E, Pickl WF, Van\u2019t Veer M, Morilla R, Swansbury J, Strobl H, et al. Mixed-phenotype acute leukemia: clinical and laboratory features and outcome in 100 patients defined according to the WHO 2008 classification. Blood. 2011;117(11):3163\u201371.","journal-title":"Blood"},{"issue":"11","key":"753_CR2","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.3324\/haematol.2012.064485","volume":"97","author":"L Yan","year":"2012","unstructured":"Yan L, Ping N, Zhu M, Sun A, Xue Y, Ruan C, et al. Clinical, immunophenotypic, cytogenetic, and molecular genetic features in 117 adult patients with mixed-phenotype acute leukemia defined by WHO-2008 classification. Haematologica. 2012;97(11):1708\u201312.","journal-title":"Haematologica"},{"issue":"7","key":"753_CR3","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1038\/s41375-018-0058-4","volume":"32","author":"M Maruffi","year":"2018","unstructured":"Maruffi M, Sposto R, Oberley MJ, Kysh L, Orgel E. Therapy for children and adults with mixed phenotype acute leukemia: a systematic review and meta-analysis. Leukemia. 2018;32(7):1515\u201328.","journal-title":"Leukemia"},{"issue":"7727","key":"753_CR4","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/s41586-018-0436-0","volume":"562","author":"TB Alexander","year":"2018","unstructured":"Alexander TB, Gu Z, Iacobucci I, Dickerson K, Choi JK, Xu B, et al. The genetic basis and cell of origin of mixed phenotype acute leukaemia. Nature. 2018;562(7727):373\u20139.","journal-title":"Nature"},{"issue":"23","key":"753_CR5","doi-asserted-by":"publisher","first-page":"3526","DOI":"10.1182\/bloodadvances.2018023531","volume":"2","author":"W Xiao","year":"2018","unstructured":"Xiao W, Bharadwaj M, Levine M, Farnhoud N, Pastore F, Getta BM, et al. PHF6 and DNMT3A mutations are enriched in distinct subgroups of mixed phenotype acute leukemia with T-lineage differentiation. Blood Adv. 2018;2(23):3526\u201339.","journal-title":"Blood Adv"},{"issue":"9","key":"753_CR6","first-page":"773","volume":"138","author":"D Di Giacomo","year":"2021","unstructured":"Di Giacomo D, La Starza R, Gorello P, Pellanera F, Kalender Atak Z, De Keersmaecker K, et al. 14q32 rearrangements deregulating BCL11B mark a distinct subgroup of T-lymphoid and myeloid immature acute leukemia. Blood. 2021;138(9):773\u201384.","journal-title":"Blood"},{"issue":"1","key":"753_CR7","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s00428-022-03448-8","volume":"482","author":"AS Duffield","year":"2023","unstructured":"Duffield AS, Mullighan CG, Borowitz MJ. International Consensus Classification of acute lymphoblastic leukemia\/lymphoma. Virchows Arch Int J Pathol. 2023;482(1):11\u201326.","journal-title":"Virchows Arch Int J Pathol"},{"issue":"7","key":"753_CR8","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1038\/s41375-022-01613-1","volume":"36","author":"JD Khoury","year":"2022","unstructured":"Khoury JD, Solary E, Abla O, Akkari Y, Alaggio R, Apperley JF, et al. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic\/Dendritic Neoplasms. Leukemia. 2022;36(7):1703\u201319.","journal-title":"Leukemia"},{"issue":"11","key":"753_CR9","doi-asserted-by":"publisher","first-page":"2846","DOI":"10.1158\/2159-8290.CD-21-0145","volume":"11","author":"LE Montefiori","year":"2021","unstructured":"Montefiori LE, Bendig S, Gu Z, Chen X, P\u00f6l\u00f6nen P, Ma X, et al. Enhancer Hijacking Drives Oncogenic BCL11B Expression in Lineage-Ambiguous Stem Cell Leukemia. Cancer Discov. 2021;11(11):2846\u201367.","journal-title":"Cancer Discov"},{"key":"753_CR10","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2025.287793","author":"O SherbanA, Wolach","year":"2025","unstructured":"SherbanA,Wolach O. Acute leukemia of ambiguous lineage: the known and the uncertain. Haematologica. 2025. https:\/\/doi.org\/10.3324\/haematol.2025.287793","journal-title":"Haematologica"},{"issue":"2","key":"753_CR11","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1111\/bjh.19363","volume":"205","author":"GA Botten","year":"2024","unstructured":"Botten GA, Zhang Y, Fuda F, Koduru P, Weinberg OK, Slone TL, et al. T\/myeloid mixed phenotype acute leukaemia harbouring TLX3::BCL11B with TLX3 activation. Br J Haematol. 2024;205(2):607\u201312.","journal-title":"Br J Haematol"},{"issue":"8027","key":"753_CR12","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1038\/s41586-024-07807-0","volume":"632","author":"P P\u00f6l\u00f6nen","year":"2024","unstructured":"P\u00f6l\u00f6nen P, Di Giacomo D, Seffernick AE, Elsayed A, Kimura S, Benini F, et al. The genomic basis of childhood T-lineage acute lymphoblastic leukaemia. Nature. 2024;632(8027):1082\u201391.","journal-title":"Nature"},{"key":"753_CR13","doi-asserted-by":"publisher","first-page":"106539","DOI":"10.1016\/j.leukres.2021.106539","volume":"103","author":"JH Reid","year":"2021","unstructured":"Reid JH, Perissinotti AJ, Benitez LL, Boyer D, Lee W, Burke PW, et al. Hybrid chemotherapy regimen (FLAG-IDA-vincristine-prednisone) for acute leukemia with mixed-phenotype blasts. Leuk Res. 2021;103:106539.","journal-title":"Leuk Res"},{"issue":"11","key":"753_CR14","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.5858\/arpa.2018-0220-RA","volume":"142","author":"SL Skala","year":"2018","unstructured":"Skala SL, Lucas DR, Dewar R. Histiocytic Sarcoma: Review, Discussion of Transformation From B-Cell Lymphoma, and Differential Diagnosis. Arch Pathol Lab Med. 2018;142(11):1322\u20139.","journal-title":"Arch Pathol Lab Med"},{"issue":"9","key":"753_CR15","doi-asserted-by":"publisher","first-page":"e31100","DOI":"10.1002\/pbc.31100","volume":"71","author":"JC Thellman","year":"2024","unstructured":"Thellman JC, Fang MM, Neff T, Thomas G, Frerich C, Press R, et al. Clonally related benign cephalic histiocytosis, histiocytic sarcoma, and T-cell acute lymphoblastic leukemia: Expanding the spectrum of histiocytic transdifferentiation. Pediatr Blood Cancer. 2024;71(9):e31100.","journal-title":"Pediatr Blood Cancer"},{"issue":"4","key":"753_CR16","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1158\/0008-5472.CAN-06-2615","volume":"67","author":"S Nagel","year":"2007","unstructured":"Nagel S, Scherr M, Kel A, Hornischer K, Crawford GE, Kaufmann M, et al. Activation of TLX3 and NKX2-5 in t(5;14)(q35;q32) T-cell acute lymphoblastic leukemia by remote 3\u2019-BCL11B enhancers and coregulation by PU.1 and HMGA1. Cancer Res. 2007;67(4):1461\u201371.","journal-title":"Cancer Res"},{"issue":"3","key":"753_CR17","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1002\/pbc.22850","volume":"56","author":"JL Oliveira","year":"2011","unstructured":"Oliveira JL, Kumar R, Khan SP, Law ME, Erickson-Johnson M, Oliveira AM, et al. Successful treatment of a child with T\/myeloid acute bilineal leukemia associated with TLX3\/BCL11B fusion and 9q deletion. Pediatr Blood Cancer. 2011;56(3):467\u20139.","journal-title":"Pediatr Blood Cancer"},{"key":"753_CR18","doi-asserted-by":"publisher","first-page":"1715087","DOI":"10.3389\/fped.2025.1715087","volume":"13","author":"M Karasek","year":"2025","unstructured":"Karasek M, Kubiszewska I, Sobas M. Mixed phenotype acute leukemia, the dissection of an enigmatic disease in the era of novel therapies. Front Pediatr. 2025;13:1715087.","journal-title":"Front Pediatr"},{"issue":"19","key":"753_CR19","doi-asserted-by":"publisher","first-page":"2350","DOI":"10.1182\/blood.2025028985","volume":"146","author":"LE Montefiori","year":"2025","unstructured":"Montefiori LE, Iacobucci I, Gao Q, Moore J, Wright WC, Wei H, et al. Venetoclax plus gilteritinib is effective in preclinical models of FLT3-mutant BCL11B-a lineage-ambiguous leukemia. Blood. 2025;146(19):2350\u20136.","journal-title":"Blood"},{"issue":"11","key":"753_CR20","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1056\/NEJMoa1403088","volume":"371","author":"KG Roberts","year":"2014","unstructured":"Roberts KG, Li Y, Payne-Turner D, Harvey RC, Yang YL, Pei D, et al. Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia. N Engl J Med. 2014;371(11):1005\u201315.","journal-title":"N Engl J Med"},{"issue":"11","key":"753_CR21","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1016\/j.clml.2025.05.013","volume":"25","author":"H Goulart","year":"2025","unstructured":"Goulart H, Jabbour E, Short NJ, Kadia TM, Pemmaraju N, Takahashi K, et al. A Phase I\/II Trial of Ruxolitinib with Chemotherapy for Patients with Relapsed and\/or Refractory Philadelphia-like Acute Lymphoblastic Leukemia. Clin Lymphoma Myeloma Leuk. 2025;25(11):800\u20137.","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"21","key":"753_CR22","doi-asserted-by":"publisher","first-page":"3458","DOI":"10.3390\/cancers17213458","volume":"17","author":"CY Ok","year":"2025","unstructured":"Ok CY, Tang G, Loghavi S, Hu S, Wei Q, Quesada AE, et al. Comparative Analysis of Targeted RNA-Seq and Optical Genome Mapping for Detecting Gene Rearrangements in Acute Leukemia. Cancers. 2025;17(21):3458.","journal-title":"Cancers"},{"issue":"14","key":"753_CR23","doi-asserted-by":"publisher","first-page":"3376","DOI":"10.3390\/cancers14143376","volume":"14","author":"A Puiggros","year":"2022","unstructured":"Puiggros A, Ramos-Campoy S, Kamaso J, de la Rosa M, Salido M, Melero C, et al. Optical Genome Mapping: A Promising New Tool to Assess Genomic Complexity in Chronic Lymphocytic Leukemia (CLL). Cancers. 2022;14(14):3376.","journal-title":"Cancers"},{"issue":"12","key":"753_CR24","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1016\/j.jmoldx.2022.09.009","volume":"24","author":"NS Sahajpal","year":"2022","unstructured":"Sahajpal NS, Mondal AK, Tvrdik T, Hauenstein J, Shi H, Deeb KK, et al. Clinical Validation and Diagnostic Utility of Optical Genome Mapping for Enhanced Cytogenomic Analysis of Hematological Neoplasms. J Mol Diagn. 2022;24(12):1279\u201391.","journal-title":"J Mol Diagn"},{"issue":"9","key":"753_CR25","doi-asserted-by":"publisher","first-page":"2306","DOI":"10.1038\/s41375-022-01652-8","volume":"36","author":"H Yang","year":"2022","unstructured":"Yang H, Garcia-Manero G, Sasaki K, Montalban-Bravo G, Tang Z, Wei Y, et al. High-resolution structural variant profiling of myelodysplastic syndromes by optical genome mapping uncovers cryptic aberrations of prognostic and therapeutic significance. Leukemia. 2022;36(9):2306\u201316.","journal-title":"Leukemia"}],"container-title":["Molecular Cytogenetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13039-026-00753-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13039-026-00753-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13039-026-00753-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T13:29:06Z","timestamp":1774618146000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13039-026-00753-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,22]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["753"],"URL":"https:\/\/doi.org\/10.1186\/s13039-026-00753-8","relation":{},"ISSN":["1755-8166"],"issn-type":[{"value":"1755-8166","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,22]]},"assertion":[{"value":"14 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"University of Michigan IRB approval (HUM00264323).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"13"}}